We offer high specification Leuprorelin Acetate CAS 74381-53-6. Leuprorelin Acetate widely used to treat prostate cancer or breast cancer.

Leuprolide injection comes as a long-acting suspension (Lupron) that is injected intramuscularly (into a muscle) by a doctor or nurse and is usually given once a month (Lupron Depot, Lupron Depot-PED) or every 3, 4, or 6 months (Lupron Depot-3 month, Lupron Depot-PED-3 month, Lupron Depot-4 month, Lupron Depot-6 Month). Leuprolide injection also comes as a long-acting suspension (Eligard) that is injected subcutaneously (just under the skin) by a doctor or nurse in a medical office or clinic and is usually given every 1, 3, 4, or 6 months.

The Leuprorelin Acetate common side effective include allergic reaction; tumour flare; hot flushes and sweats sexual effects; tiredness Headaches; skin changes; dizziness, blurred vision, drowsiness and so on.

Thera. Category: Anti-neoplastic

Cas No.: 74381-53-6

Synonym: leutenizinghormone-releasingfactor(pig),6-d-leucine-9-(n-ethyl-l-prolinamid;lupron;tap-144;tap-144-sr;DES-GLY10,[P-LEU6]-LH-RH ETHYLAMIDE;[DES-GLY10, D-LEU6, PRO-NHET9]-LH-RH (HUMAN);(DES-GLY10,D-LEU6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING FACTOR;(DES-GLY10,D-LEU6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING HORMONE

Molecular Formula: C59H84N16O12.C2H4O2

Molecular Weight: 1269.46

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Topical anti-inflammatory corticosteroidSynthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal)